Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123430972 | 12343097 | 2 | F | 2016 | 20160630 | 20160506 | 20160708 | EXP | US-INCYTE CORPORATION-2016IN002561 | INCYTE | 81.32 | YR | F | Y | 73.92000 | KG | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123430972 | 12343097 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, BID | Y | U | 202192 | 10 | MG | TABLET | |||||
| 123430972 | 12343097 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 3 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 4 | C | PROTONIX /00661201/ | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 5 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 8 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 9 | C | VITAMIN B | VITAMIN B | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 10 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 11 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 12 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 13 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 0 | INHALER | |||||||||
| 123430972 | 12343097 | 14 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 15 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 16 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | 500 MG | 0 | ||||||||||
| 123430972 | 12343097 | 17 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 18 | C | HEPARIN | HEPARIN SODIUM | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 19 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 20 | C | NYSTATIN. | NYSTATIN | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 21 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 22 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 123430972 | 12343097 | 23 | C | VANCOMYCIN | VANCOMYCIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123430972 | 12343097 | 1 | Myelofibrosis |
| 123430972 | 12343097 | 2 | Pulmonary oedema |
| 123430972 | 12343097 | 3 | Product used for unknown indication |
| 123430972 | 12343097 | 4 | Product used for unknown indication |
| 123430972 | 12343097 | 5 | Product used for unknown indication |
| 123430972 | 12343097 | 6 | Product used for unknown indication |
| 123430972 | 12343097 | 7 | Product used for unknown indication |
| 123430972 | 12343097 | 8 | Product used for unknown indication |
| 123430972 | 12343097 | 9 | Product used for unknown indication |
| 123430972 | 12343097 | 10 | Product used for unknown indication |
| 123430972 | 12343097 | 11 | Product used for unknown indication |
| 123430972 | 12343097 | 12 | Product used for unknown indication |
| 123430972 | 12343097 | 13 | Product used for unknown indication |
| 123430972 | 12343097 | 14 | Product used for unknown indication |
| 123430972 | 12343097 | 15 | Product used for unknown indication |
| 123430972 | 12343097 | 16 | Product used for unknown indication |
| 123430972 | 12343097 | 17 | Product used for unknown indication |
| 123430972 | 12343097 | 18 | Product used for unknown indication |
| 123430972 | 12343097 | 19 | Product used for unknown indication |
| 123430972 | 12343097 | 20 | Product used for unknown indication |
| 123430972 | 12343097 | 21 | Product used for unknown indication |
| 123430972 | 12343097 | 22 | Product used for unknown indication |
| 123430972 | 12343097 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123430972 | 12343097 | OT |
| 123430972 | 12343097 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123430972 | 12343097 | Anaemia | |
| 123430972 | 12343097 | Asthenia | |
| 123430972 | 12343097 | Candida infection | |
| 123430972 | 12343097 | Chills | |
| 123430972 | 12343097 | Contusion | |
| 123430972 | 12343097 | Cough | |
| 123430972 | 12343097 | Decreased appetite | |
| 123430972 | 12343097 | Disease progression | |
| 123430972 | 12343097 | Electrolyte imbalance | |
| 123430972 | 12343097 | Fatigue | |
| 123430972 | 12343097 | Herpes zoster | |
| 123430972 | 12343097 | Hypertension | |
| 123430972 | 12343097 | Joint swelling | |
| 123430972 | 12343097 | Nausea | |
| 123430972 | 12343097 | Oropharyngeal pain | |
| 123430972 | 12343097 | Platelet count decreased | |
| 123430972 | 12343097 | Pulmonary oedema | |
| 123430972 | 12343097 | Sepsis | |
| 123430972 | 12343097 | Thrombocytopenia | |
| 123430972 | 12343097 | Urinary tract infection | |
| 123430972 | 12343097 | Vomiting | |
| 123430972 | 12343097 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123430972 | 12343097 | 1 | 2013 | 20160329 | 0 |